SCHEMBL6999984

SCHEMBL6999984

CCCCCCCC(=O)c1cc2sc3sccc3c2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 2/20 0.41
HSD17B3 P37058 6/20 0.38
CA2 P00918 1/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
PLA2G2A P14555 2/20 0.37
PLA2G5 P39877 2/20 0.37
FFAR1 O14842 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37
HPGD P15428 2/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
ALOX12 P18054 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17086928 0.83 GPR35 (0.44) GPR35HSD17B3CA2ALDH1A1MAPT
SCHEMBL17086893 0.82 GPR35 (0.48) GPR35HSD17B3CA2ALDH1A1MAPT
SCHEMBL15274423 0.81 GPR35 (0.46) GPR35HSD17B3CA2ALDH1A1MAPT
SCHEMBL12345757 0.81 GPR35 (0.40) GPR35HSD17B3CA2ALDH1A1MAPT
SCHEMBL12345756 0.81 GPR35 (0.40) GPR35HSD17B3CA2ALDH1A1MAPT
SCHEMBL12966637 0.80 GPR35 (0.40) GPR35HSD17B3CA2ALDH1A1MAPT
SCHEMBL12821718 0.80 HSD17B3 (0.42) GPR35HSD17B3CA2ALDH1A1MAPT
SCHEMBL6526414 0.79 GPR35 (0.53) GPR35HSD17B3CA2ALDH1A1MAPT
SCHEMBL6999797 0.75 GPR35 (0.56) GPR35ALDH1A1MAPTMEN1KMT2A
SCHEMBL23510106 0.73 GPR35 (0.56) GPR35HSD17B3CA2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017735-B1 COMPOUNDS FOR ELECTRONIC DEVICES CAMBRIDGE DISPLAY TECH LTD (GB) 2003-11-19 EP disclosed
US-6626566-B2 Comprising at least two moieties, each moiety being comprised of two or more thiophenes fused directly to each other; used to fabricate thin-film transistors (TFTs) or field-effect transistors (FETs). CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2003-09-30 US disclosed
US-20030088112-A1 Compounds for electronic devices CAMBRIDGE DISPLAY TECHONOLOGY LIMITED 2003-05-08 US disclosed
US-6403809-B1 FUSED THIOPHENE OLIGOMERS OR POLYMERS FOR LIGHT-EMITTING DIODES OR THIN FILM TRANSISTORS CAMBRIDGE DISPLAY TECHNOLOG LIMITED (GB) 2002-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088112-A1 Compounds for electronic devices TERT, TST, DDT GPR35 4183/4885HSD17B3 2795/4885CA2 2862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.